← All organizations

BioVex

For profitContributed to NME

Also known as: BioVex Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2011

Acquired by Amgen on Jan 1, 2011

Timeline

2000s

Jan 1, 2006
BioVex— Founded

2010s

Jan 1, 2011
Amgen— Acquired By

Drugs by trial phase (3 distinct, 6 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT01161498Lead sponsorPhase 3Feb 1, 2011
NCT01368276Lead sponsorPhase 3Oct 1, 2010
NCT00769704Lead sponsorPhase 3Apr 1, 2009
NCT02574260Lead sponsorPhase 2Aug 1, 2008
NCT00402025Lead sponsorPhase 1Nov 1, 2006
NCT00402025Study directorPhase 1Nov 1, 2006
NCT00289016Lead sponsorPhase 2Dec 1, 2005
NCT00289016Study directorPhase 2Dec 1, 2005

Details

Founded: Oxton, GB Jan 1, 2006
Last known activity: Feb 1, 2011